T. Rowe Price Associates
CLVT icon

T. Rowe Price Associates’s Clarivate CLVT Stock Holding History

T. Rowe Price Associates’s Portfolio CLVT Stock Details CLVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$991K Buy
458,555
+141,512
+45% +$346K ﹤0.01% 2340
2026
Q1 		$803K Buy
317,043
+20,391
+7% +$52.2K ﹤0.01% 2249
2025
Q4 		$991K Sell
296,652
-93,431
-24% -$332K ﹤0.01% 2084
2025
Q3 		$1.5M Buy
390,083
+18,570
+5% +$78K ﹤0.01% 1869
2025
Q2 		$1.6M Sell
371,513
-11,722,083
-97% -$47.2M ﹤0.01% 1750
2025
Q1 		$47.5M Sell
12,093,596
-15,683,296
-56% -$74.3M 0.01% 738
2024
Q4 		$141M Buy
27,776,892
+9,691,104
+54% +$55.8M 0.02% 498
2024
Q3 		$128M Buy
18,085,788
+17,843,176
+7,355% +$114M 0.01% 517
2024
Q2 		$1.38M Sell
242,612
-4,834
-2% -$30.8K ﹤0.01% 1742
2024
Q1 		$1.84M Buy
247,446
+13,103
+6% +$109K ﹤0.01% 1605
2023
Q4 		$2.17M Buy
234,343
+15,609
+7% +$115K ﹤0.01% 1484
2023
Q3 		$1.47M Buy
218,734
+11,956
+6% +$95.3K ﹤0.01% 1612
2023
Q2 		$1.97M Sell
206,778
-1,193
-0.6% -$10.1K ﹤0.01% 1481
2023
Q1 		$1.95M Buy
207,971
+25,883
+14% +$267K ﹤0.01% 1464
2022
Q4 		$1.52M Sell
182,088
-46,526
-20% -$437K ﹤0.01% 1572
2022
Q3 		$2.15M Sell
228,614
-30,656,417
-99% -$388M ﹤0.01% 1426
2022
Q2 		$428M Buy
30,885,031
+24,948
+0.1% +$373K 0.05% 323
2022
Q1 		$517M Sell
30,860,083
-13,231,980
-30% -$219M 0.05% 324
2021
Q4 		$1.04B Sell
44,092,063
-4,477,503
-9% -$104M 0.09% 216
2021
Q3 		$1.06B Sell
48,569,566
-20,680,975
-30% -$503M 0.1% 211
2021
Q2 		$1.91B Sell
69,250,541
-4,810,730
-6% -$132M 0.18% 124
2021
Q1 		$1.95B Buy
74,061,271
+6,725,140
+10% +$184M 0.2% 111
2020
Q4 		$2B Buy
67,336,131
+8,904,743
+15% +$263M 0.21% 112
2020
Q3 		$1.81B Sell
58,431,388
-1,271,171
-2% -$34.4M 0.21% 100
2020
Q2 		$1.33B Buy
59,702,559
+14,066,555
+31% +$318M 0.17% 127
2020
Q1 		$947M Buy
45,636,004
+7,667,477
+20% +$153M 0.15% 145
2019
Q4 		$638M Buy
37,968,527
+10,222,339
+37% +$172M 0.08% 258
2019
Q3 		$468M Buy
27,746,188
+25,814,998
+1,337% +$427M 0.07% 290
2019
Q2 		$29.7M Buy
+1,931,190
New +$26.9M ﹤0.01% 1057

Other funds holding CLVT

LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates's CLVT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Clarivate (CLVT) stake by 45% in Q2 2026, buying an estimated $346K and bringing the position to 458,555 shares worth $991K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

T. Rowe Price Associates first reported a position in CLVT in Q2 2019 and has held it in 29 quarters since. The position peaked at $2B in Q4 2020. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • T. Rowe Price Associates held 458,555 shares of Clarivate worth $991K as of Q2 2026.
  • T. Rowe Price Associates bought 141,512 Clarivate shares in Q2 2026, an estimated $346K.
  • Clarivate made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2340 holding.
  • T. Rowe Price Associates first reported a position in Clarivate in Q2 2019 and has held it in 29 quarters since.
  • T. Rowe Price Associates's Clarivate position peaked at $2B in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.